MassMutual Private Wealth & Trust’s Adaptive Biotechnologies ADPT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50	Closed	-$336	–	1966
2023 Q2	$336	Hold	50	–	–	﹤0.01%	1825
2023 Q1	$442	Hold	50	–	–	﹤0.01%	1710
2022 Q4	$0	Sell	50 -147	-75%	-$1.14K	﹤0.01%	1622
2022 Q3	$1K	Buy	+197	New	+$1.85K	﹤0.01%	1336

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

MassMutual Private Wealth & Trust's ADPT Position: Q3 2023 in Review

MassMutual Private Wealth & Trust sold out of Adaptive Biotechnologies (ADPT) in Q3 2023, closing a stake of 50 shares — an estimated $336 sold.

MassMutual Private Wealth & Trust first reported a position in ADPT in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 190 funds tracked by Wall St. Rank hold ADPT as of Q3 2023.

MassMutual Private Wealth & Trust reported no remaining Adaptive Biotechnologies position as of Q3 2023 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 50 Adaptive Biotechnologies shares in Q3 2023, an estimated $336.
MassMutual Private Wealth & Trust first reported a position in Adaptive Biotechnologies in Q3 2022 and held it in 4 quarters.
MassMutual Private Wealth & Trust's Adaptive Biotechnologies position peaked at $1K in Q3 2022.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2023, filed 4 Oct 2023.